Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Foie
»
Néoplasie
03. Février 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Hépatite
Cirrhose du foie
Néoplasie
Hypertonie portale
Autres
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 3754
Articles 1 - 20 / 75070
Impact of microvascular invasion on clinical outcomes in hepatocellular carcinoma patients following liver transplantation.
Medicine (Baltimore)
Yan Q, Deng J, Liu Y, Wang FJ, Chen HW.
PMID: 41630216 [PubMed - indexed for MEDLINE]
Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis.
PLoS Med
Li ZY, Li HL, Wang J, Shen QM, Zou YX, Yang DN, Tan YT, Xiang YB.
PMID: 41628182 [PubMed - indexed for MEDLINE]
The prognostic value of systemic immune-inflammation index and prognostic nutritional index for colorectal cancer cases with liver metastasis post-transcatheter arterial chemoembolization.
Future Oncol
Tan X, Wu J, Jin Z.
PMID: 41627924 [PubMed - indexed for MEDLINE]
Burden, trends and projections of liver cancer in China and G20 countries: a comparative study based on the global burden of disease database 2021.
Front Public Health
He YF, Liu YM, Ren BN, An J, Wu YP, Zhao JQ, Ma YL, He W, Wu HZ.
PMID: 41626390 [PubMed - indexed for MEDLINE]
Lactylation: the malignant playbook of hepatocellular carcinoma cells and their roadmap to therapy resistance.
Front Immunol
Li S, Lu X, Zhang L.
PMID: 41624887 [PubMed - indexed for MEDLINE]
The PLANES model for unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus lenvatinib and PD-1 inhibitors: a multicenter, retrospective study.
Front Immunol
Ya H, Wang K, Wu J, Wu J, Zeng Z, Li Y, Ou X, Song H, Yan M, Li S.
PMID: 41624866 [PubMed - indexed for MEDLINE]
Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification.
JCO Clin Cancer Inform
Mojtahedi R, Hamghalam M, Peoples JJ, Jarnagin WR, Do RKG, Simpson AL.
PMID: 41616240 [PubMed - indexed for MEDLINE]
Isolated Hepatic Hemangiomatosis Leading to Fatal Consumptive Coagulopathy in an Elderly Patient: A Case Report.
Am J Case Rep
, Oszytko JK, Chlebowska GM.
PMID: 41615903 [PubMed - indexed for MEDLINE]
Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma.
Oncol Res
Kim HS, Son JA, Kang M, Kim SS, Baek GO, Yoon MG, Jang SH, Jung D, Han JE, Cheong JY, Eun JW.
PMID: 41613803 [PubMed - indexed for MEDLINE]
Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study.
J Med Internet Res
Liu Z, Li M, Jia Y, Chen L.
PMID: 41610421 [PubMed - indexed for MEDLINE]
Differential survival benefit of curative versus non-curative intent treatment in a real-world cohort with early and intermediate-stage hepatocellular carcinoma.
Hepatol Commun
Goldberg D, John B, Kaplan D, Delgado C, Gaddipati N, Gaddipati S, Blandon C.
PMID: 41610143 [PubMed - indexed for MEDLINE]
Survival Prediction and Treatment Decisions in Hepatocellular Carcinoma: A Deep Learning-Based Radiomics Approach.
Br J Hosp Med (Lond)
Wei X, Xiao J, Liu Y, Yang C, Luo Z, Tang M, Chen X.
PMID: 41609156 [PubMed - indexed for MEDLINE]
Improving Survival Models in Health Care by Balancing Imbalanced Cohorts: A Novel Approach.
JCO Clin Cancer Inform
Ning C, Bertsimas D, Lønning PE, Auecio FN, Burkhart R, Balzer F, Buettner S, Baba H, Endo I, Stasinos G, Gagnière J, Verhoef C, Kreis ME, Margonis GA.
PMID: 41604602 [PubMed - indexed for MEDLINE]
Single-cell transcriptomics reveals a novel mechanism of RDH16 regulating immune infiltration in hepatocellular carcinoma.
Front Immunol
Zhang Z, Fan R, Ma J, Li D, Jiang Y, Liu F, Gong Q.
PMID: 41601632 [PubMed - indexed for MEDLINE]
Immune cell metabolic reprogramming in hepatocellular carcinoma: mechanisms, tumor microenvironment, and future immunotherapeutic directions.
Front Immunol
Zhou L, Zhang W, Liu Z, Xie Y, Jiang K.
PMID: 41601626 [PubMed - indexed for MEDLINE]
Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk.
Molecules
Osredkar J, Rakusa M, Jerin A, , Zaplotnik M, , Siuka D.
PMID: 41599322 [PubMed - indexed for MEDLINE]
Role of Liver Function in the Multiparametric Assessment of Hepatocellular Carcinoma.
Medicina (Kaunas)
Melandro F, Centonze L, Celsa C, Famularo S, Ghinolfi D, Nardelli S, Pallozzi M, Abenavoli L, Romano F, Ponziani FR, Russo FP, Lai Q.
PMID: 41597423 [PubMed - indexed for MEDLINE]
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges.
Cells
Lo Re O, Corti C, Cerrito L, Cesari E, Creta E, De Maio F, Di Prima A, Facciuto V, Ferraro C, Huqi E, Liotta R, Lo Pinto M, Pagano D, Perriera R, Petito V, Santarelli G, Santopaolo F, Stella L, Tortomasi F, Sette C, Gruttadauria S, Giuliante F, Zito G, Ponziani FR.
PMID: 41597200 [PubMed - indexed for MEDLINE]
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.
Cancer Immunol Immunother
Shin H, Park Y, Song BG, Choi WM, Han HJ, Lee Y, Song TJ, Yeon JE, Lim YS, Hur MH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Lee JH, Yoon JH, Lee JH.
PMID: 41591582 [PubMed - indexed for MEDLINE]
Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab.
Cancer Immunol Immunother
Chen IW, Lin CW, Lin PT, Teng W, Su CW, Wu TH, Hsieh YC, Chen WT, Lin CC, Lin SM, Lin CY.
PMID: 41591568 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 75070
Page 1 de 3754
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité